Sports medicine startup, Biomimedica, raises $14M for synthetic cartilage to repair joints

Biomimedica® Announces the Closing of its Oversubscribed Series B Financing (press release)
 

Biomimedica®, Incorporated (www.biomimedica.com), a medical device start-up company focused on the development and commercialization of its proprietary GRADION™ Total Cartilage Replacement™ (“TCR™”) technology, announced today that it has closed its Series-B financing, raising $11.9 million from a combination of new and existing investors, including conversion of approximately $2.8 million in bridge loans. Participants in this round include new investors Troika Ventures (Russia) and Biedermann M...